This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

TeamHealth Anesthesia Names Aryeh Shander, MD, Director Of Research

Stocks in this article: TMH

KNOXVILLE, Tenn., Sept. 3, 2013 /PRNewswire/ -- TeamHealth, one of the nation's largest providers of outsourced physician staffing solutions for hospitals, announces the appointment of Aryeh Shander, MD, FCCM, FCCP, as director of research for TeamHealth Anesthesia, effective Sept. 1. In his new role, Dr. Shander will work to improve clinical outcomes through the direction and coordination of all TeamHealth Anesthesia clinical research initiatives.

"Dr. Shander is a passionate researcher and true innovator in the field of anesthesiology and patient blood management, and we are proud to have him as part of our team," said Sonya Pease, MD, chief medical officer for TeamHealth Anesthesia. "We look forward to the opportunity to learn from his experience and expertise and work together to improve care for all of the patients and families we serve nationwide."

Dr. Shander founded Englewood, N.J.-based Northern Valley Anesthesiology (NVA), which provides comprehensive anesthesia, critical care and pain management services to Englewood Hospital and Medical Center as well as five ambulatory surgery centers in northern New Jersey. He joined TeamHealth in January 2013, when NVA was acquired by TeamHealth.

Dr. Shander is an internationally respected expert who is particularly regarded for his innovations and skill in managing patients with minimal to no blood transfusion. He is a founding member of the Society for the Advancement of Blood Management (SABM), a leading organization in the development of effective blood management strategies. Throughout his career Dr. Shander has authored numerous articles and books in the fields of anesthesiology, critical care, transfusion medicine and other disciplines. He has served as the primary investigator for clinical trials and other breakthrough medical studies and as a reviewer for many medical journals. In 1997, Dr. Shander was recognized by Time magazine as one of America's "Heroes of Medicine." Additionally, Dr. Shander serves as chief of the departments of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine at Englewood Hospital and Medical Center. He also serves as clinical professor of Anesthesiology, Medicine and Surgery at Icahn School of Medicine at Mount Sinai in New York City.

About TeamHealthTeamHealth ( Knoxville, Tenn.) (NYSE: TMH) is one of the largest providers of outsourced physician staffing solutions for hospitals in the United States. Through its 18 regional locations and multiple service lines, TeamHealth's more than 8,900 affiliated healthcare professionals provide emergency medicine, hospital medicine, anesthesia, urgent care, and pediatric staffing and management services to more than 800 civilian and military hospitals, clinics, and physician groups in 47 states. The term "TeamHealth" as used throughout this release includes Team Health, Inc., and all of its related entities, divisions, subsidiaries and affiliated physicians and physician groups. For more information about TeamHealth, visit www.teamhealth.com.

SOURCE TeamHealth

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs